title: Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction.
abstract: Depressed parasympathetic activity has been proposed to be associated with an increased risk of sudden death. Parasympathetic effects (PE) on cardiac electrophysiology during exercise and recovery have not been studied in patients with left ventricular dysfunction. We performed noninvasive electrophysiological studies (NI-EPS) and characterized the electrophysiological properties of the sinus node, atrioventricular (AV) node, and ventricle in subjects with depressed left ventricular ejection fraction and dual-chamber defibrillators. NI-EPS were performed during rest, exercise, and recovery at baseline and after parasympathetic blockade with atropine to assess PE (the difference between parameter values in the 2 conditions). Ten subjects (9 men: age, 60 +/- 9 yr; and left ventricular ejection fraction, 29 +/- 8%) completed the study. All NI-EPS parameters decreased during exercise and trended toward rest values during recovery. PE at rest, during exercise, and during recovery, respectively, were on sinus cycle length, 320 +/- 71 (P = 0.0001), 105 +/- 60 (P = 0.0003), and 155 +/- 82 ms (P = 0.0002); on AV block cycle length, 137 +/- 136 (P = 0.09), 37 +/- 19 (P = 0.002), and 61 +/- 39 ms (P = 0.006); on AV interval, 58 +/- 32 (P = 0.035), 22 +/- 13 (P = 0.002), and 36 +/- 20 ms (P = 0.001); on ventricular effective refractory period, 15.8 +/- 11.3 (P = 0.02), 4.7 +/- 15.2 (P = 0.38), and 6.8 +/- 15.5 ms (P = 0.20); and on QT interval, 13 +/- 12 (P = 0.13), 3 +/- 17 (P = 0.6), and 20 +/- 23 (P = 0.04). In conclusion, we describe for the first time the changes in cardiac electrophysiology and PE during rest, exercise, and recovery in subjects with left ventricular dysfunction. PEs are preserved in these patients. Thus the role of autonomic changes in the pathophysiology of sudden death requires further exploration.
authors.affiliation: Division of Cardiology, Bluhm Cardiovascular Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
authors.forename: Alexandru B
authors.initials: AB
authors.lastname: Chicos
authors.forename: Prince J
authors.initials: PJ
authors.lastname: Kannankeril
authors.forename: Alan H
authors.initials: AH
authors.lastname: Kadish
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Goldberger
mesh_terms: D000368:Aged; D054537:Atrioventricular Block / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001283:Atrioventricular Node / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D001285:Atropine / Q000008:administration & dosage*; D001794:Blood Pressure / Q000502:physiology; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D015444:Exercise / Q000502:physiology*; D005260:Female; D006333:Heart Failure / Q000503:physiopathology; D006339:Heart Rate / Q000502:physiology; D006352:Heart Ventricles / Q000294:innervation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010275:Parasympathetic Nervous System / Q000187:drug effects* / Q000502:physiology*; D010276:Parasympatholytics / Q000008:administration & dosage*; D012146:Rest / Q000502:physiology; D012849:Sinoatrial Node / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D013318:Stroke Volume / Q000502:physiology; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology*
chemical_list: D010276:Parasympatholytics; D001285:Atropine